ArticleBMC medical genomics2025
An intron SNP rs666088 in SLIT2 increases the risk of acute coronary syndrome in an Iranian population.
Article in BMC medical genomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe Slit guidance Ligand 2 (SLIT2) glycoprotein is of particular interest because of its role in modulating inflammation and the progression of diseases such as atherosclerosis. This study aimed to determine whether SLIT2 polymorphisms can serve as predictive markers for coronary artery disease (CAD) development by investigating its single-nucleotide polymorphisms (SNPs).
methodsIn this case-control study, a total of 321 participants including 217 patients with diagnosed CAD and 104 healthy controls were recruited. Patients were divided into acute coronary syndrome (ACS) (n = 153) and stable angina pectoris (SAP) (n = 64). Allele and genotype frequency of SLIT2 SNP variants rs666088 C > T and rs16869521 A > T were determined using Polymerase Chain Reaction with Sequence-Specific Primers (PCR-SSP). Odds ratios (ORs) were reported along with their 95% confidence intervals (CIs) and P-values. Crude estimates were initially presented, followed by adjusted ORs computed using logistic regression, controlling for potential confounders including age, gender, high-density lipoprotein (HDL) levels, fasting blood sugar (FBS), and smoking status.
resultsThe frequencies of the T allele of rs666088 were significantly higher in ACS patients compared to healthy controls, and were associated with an increased risk of ACS both before (OR = 1.5, 95% CI = 1.1–2.2, P = 0.01) and after adjustment for confounding factors (OR = 1.3, 95% CI = 1.1–1.9, P = 0.02). Moreover, analysis of ACS subgroups—myocardial infarction (MI) and unstable angina pectoris (UAP), revealed consistent results. However, the allele and genotype frequencies of rs16869521 were not significantly different between patients and controls in any disease categories.
conclusionsOur study revealed that genetic polymorphism of SLIT2 (rs666088) TT genotype and T allele is the potential host genetic risk factor for ACS. Therefore, SLIT2 (rs666088) genetic variation may be considered as a biomarker for early screening and diagnosis of the disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.